Reports and Surveys

• CPT Table: # of ARVs patented in each country in Sub-Saharan Africa, along with figures on PWAs, population, and income.
• October 17, 2001. Amir Attaran and Lee Gillespie-White. Journal of the American Medical Association Vol. 286 No.15. Do Patents for Antiretroviral Drugs Constrain Access to AIDS Treatment in Africa? (Also available in a pdf format.) Also see the Letters to the Editor in response to this study, published in the February 20, 2002 issue.
• October 17, 2001. Joint Statement by Oxfam, Treatment Action Campaign, Consumer Project on Technology(CPT) Médecins Sans Frontières (MSF) and Health GAP. Patents Do Matter in Africa According to NGOs.
• October 16, 2001. CPT, Essential Action, Treatment Access Campaign, Oxfam, HealthGAP. Comment on the Attaran/Gillespie-White and PhRMA surveys of patents on Antiretroviral drugs in Africa.
• October 6, 2001. CPT. Where are the sub-Saharan patents filed, in terms of population, infection rates and incomes?
• October 5, 2001. CPT HIV patients in countries with ARV patents in Sub-Saharan Africa.
• September 30, 2001. PhRMA survey. Facts and Figures on Patenting and Access in Africa.